Please enable JS

DISCOVER

CT-SCOUT™

Success is when the time to access an innovative treatment is reduced.

CT-SCOUT™ is a multi-device application aiming at facilitating the recruitment of patients in clinical studies...

It assists the investigational team in detecting the studies for which a patient is potentially eligible according to his/her current health conditions.

Access to CT-SCOUT™

The digital solution to boost patient recruitment in clinical trials

Transforms all physician into real time recruiters
Anywhere, anytime
On any device
Easy to use

CT-SCOUT™ unique features

1. An efficient algorithmic model

2. Real-time detection

3. Simplified
process

Therapeutic Expertise

Gastroenterology

Crohn disease
Ulcerative colitis

Dermatology

Psoriasis
Atopic dermatitis
Hidradenitis suppurativa

Rheumatology

Rheumatoid arthritis
Ankylosing spondylitis
Psoriatic arthritis

200 +

studies registered (industrial & academic)

1000 +

users registered

170 +

centers in various countries (Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Spain, Switzerland, UK…)

7000 +

Patients detected

Figure: Total R&D/clinical trials pipeline size, by year 2000-2022

They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor. CT-SCOUT™and ToTem4me facilitate the match between the patients and the studies.

50%

OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES

However, millions of patients visit clinical sites every day.
CT-SCOUT help investigators identify the ones that could benefit from a clinical study.

80%

OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY

Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.

0.02%

OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY

But 80% of patients would accept to participate t a clinical study.
CT-SCOUT contributes to increase the percentage of patients considered for clinical research.

2

WEEKS SET-UP TIME

No more than 2 weeks are required to get CT-SCOUT
or ToTem4me deployed for a clinical study

As a summary

Assist investigational teams in their clinical research activities.

Shorten clinical trials by boosting detection of patients potentially eligible to clinical trials.

Allow patients’ earlier access to innovative and life-saving treatment.

LATEST NEWSOUR NEWS >

telemedecine technologies news

AI in medtech is taking off. Here are 4 trends to watch in 2025

January 30, 2025

MedtechDive Artificial intelligence was a topic of focus for the medical device industry in 2024. Companies including GE Healthcare, Medtronic and Dexcom touted new AI features, and others like Stryker and Quest Diagnostics added AI assets through M&A. Meanwhile, conversations about regulations and generative AI, models that are trained to create new data including images and text, dominated medtech conferences. The Food and Drug Administration recently […]

READ MORE
telemedecine technologies news

FDA Provides Guidance on Advanced Manufacturing Technologies Program

January 30, 2025

BioPharm International FDA published a final guidance on Jan. 2, 2025 for those interested in participating in the agency’s Advanced Manufacturing Technologies Designation Program, which was developed to facilitate drugs manufactured using advanced manufacturing technologies (AMTs). The guidance, Advanced Manufacturing Technologies Designation Program, is the final version of the draft document issued on Dec. 13, 2023. […]

READ MORE
telemedecine technologies news

New Data Links Decentralized Clinical Trial Approaches to Improved Diversity in Patient Populations

January 30, 2025

Applied Clinical Trials Online Medable has shared new data from the Tufts Center for the Study of Drug Development (CSDD)’s PACT Consortium linking decentralized clinical trial (DCT) approaches to a higher rate in participation across multiple demographic groups. The new research shows that a more strategic implementation of DCT elements, combined with increased regulatory oversight, […]

READ MORE